Cas:175278-21-4 2-(Trifluoromethoxy)terephthalic acid manufacturer & supplier

We serve Chemical Name:2-(Trifluoromethoxy)terephthalic acid CAS:175278-21-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(Trifluoromethoxy)terephthalic acid

Chemical Name:2-(Trifluoromethoxy)terephthalic acid
CAS.NO:175278-21-4
Synonyms:2-(Trifluoromethoxy)terephthalic acid;MFCD00052320;1,4-Benzenedicarboxylic acid, 2-(trifluoromethoxy)-
Molecular Formula:C9H5F3O5
Molecular Weight:250.128
HS Code:2918990090

Physical and Chemical Properties:
Melting point:270-272°C
Boiling point:352.2±42.0 °C at 760 mmHg
Density:1.6±0.1 g/cm3
Index of Refraction:1.522
PSA:83.83000
Exact Mass:250.008911
LogP:2.85

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:3261
Packing Group:


Contact us for information like 2-(Trifluoromethoxy)terephthalic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,4-Benzenedicarboxylic acid, 2-(trifluoromethoxy)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,4-Benzenedicarboxylic acid, 2-(trifluoromethoxy)- Use and application,2-(Trifluoromethoxy)terephthalic acid technical grade,usp/ep/jp grade.


Related News: As the first-to-market BTK inhibitor, Imbruvica has been treating front-line CLL patients since its monotherapy go-ahead in early 2016. But it’s now facing competition from AstraZeneca’s Calquence, which just detailed a head-to-head safety advantage over Imbruvica in previously treated CLL. 2-(Trifluoromethoxy)terephthalic acid manufacturer Roche too has been riding high on the stock exchange this week, as investors still hope its more extensive Alzheimer’s profile could come good. 2-(Trifluoromethoxy)terephthalic acid supplier As the first-to-market BTK inhibitor, Imbruvica has been treating front-line CLL patients since its monotherapy go-ahead in early 2016. But it’s now facing competition from AstraZeneca’s Calquence, which just detailed a head-to-head safety advantage over Imbruvica in previously treated CLL. 2-(Trifluoromethoxy)terephthalic acid vendor Roche too has been riding high on the stock exchange this week, as investors still hope its more extensive Alzheimer’s profile could come good. 2-(Trifluoromethoxy)terephthalic acid factory From basic chemical raw materials to chemical preparations, complex chemical and physical processes are required. The production of chemical raw materials and intermediates concentrates the main synthetic procedures and technical links, which is the prerequisite and important guarantee for the development of the chemical pharmaceutical industry.